Methods for detection and evaluation of bladder cancer
US6350571B1 · kind B1 · utility
8Cited by
10References
8Claims
0Family size
Inventors
Key dates
| Filing date | Mar 10, 1999 |
| Grant date | Feb 26, 2002 |
| Priority date | — |
| Expiry date | Mar 10, 2019 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/81
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates to novel methods for detecting and evaluating bladder cancer. The methods of the present invention are based on the discovery that normalized amounts of hyaluronic acid (HA) and hyaluronidase (HAase) are diagnostic markers for the detection of bladder cancer, evaluation of its grade, monitoring of the efficacy of its treatment, and tumor recurrence.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.